![Dimitris Voliotis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dimitris Voliotis
Hoofd Techniek/Wetenschap/O&O bij
RADIOPHARM THERANOSTICS LIMITED
Profiel
Dimitris Voliotis currently works at Radiopharm Theranostics Ltd., as Chief Medical Officer from 2024.
Dr. Voliotis also formerly worked at CureVac SE, as Chief Development Officer from 2019 to 2020, Eisai, Inc., as Global Head-Clinical Development Oncology from 2016 to 2019, Bayer HealthCare AG, as Vice President & Head-Oncology Group from 2007 to 2014, and Zentalis Pharmaceuticals, Inc., as Senior Vice President-Clinical Development from 2020 to 2023.
Dr. Voliotis received his doctorate degree from Universität zu Köln.
Actieve functies van Dimitris Voliotis
| Bedrijven | Functie | Begin |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Hoofd Techniek/Wetenschap/O&O | 20-08-2024 |
Eerdere bekende functies van Dimitris Voliotis
| Bedrijven | Functie | Einde |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-09-2023 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Corporate Officer/Principal | 01-02-2020 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01-01-2019 |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01-09-2014 |
Opleiding van Dimitris Voliotis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
